Center for Cell Signaling in Gastroenterology, Mayo Clinic
National Institute of Diabetes and Digestive and Kidney Diseases
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
The oncogenic potential of YAP requires Y357 phosphorylation in cholangiocytes but not in hepatocytes
Chantal E. McCabe, EeeLN H. Buckarma, Muhammed Doğukan Aksu, Jayla T. Millender et al.
Journal
Cellular Oncology
Topics
Hippo pathway signaling and YAP/TAZ
article
The oncogenic potential of YAP requires Y357 phosphorylation in cholangiocytes but not in hepatocytes
Chantal E. McCabe, EeeLN H. Buckarma, Muhammed Doğukan Aksu, Jayla T. Millender, Daniel R. O’Brien, Rory Smoot, Gregory J. Gores, Caitlin B. Conboy, Rondell P. Graham, Jennifer A. Yonkus, Nathan W. Werneburg, Ryan D. Watkins
article en
Abstract
No abstract available for this paper.
Publication Tag
Cellular OncologyVol. 49(1)
Institutions
Mayo Clinic (US), Mayo Clinic in Arizona (US), Mayo Clinic in Florida (US)
Funders
Cholangiocarcinoma Foundation, National Institutes of Health, Center for Cell Signaling in Gastroenterology, Mayo Clinic, National Institute of Diabetes and Digestive and Kidney Diseases
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
The oncogenic potential of YAP requires Y357 phosphorylation in cholangiocytes but not in hepatocytes — Chantal E. McCabe, EeeLN H. Buckarma, et al. · Cellular Oncology (2025) | TGRS Research Map | TGRS